Table 1 Comparison of myPath test performance by the Reimann et al. [1] classification system vs. the clinically-validated classification system provided with the myPath test results
From: Reply to Reimann et al.
Case type | Reference standard | Analysis | Reported by Reimann et al. [1] | Using validated myPath test results |
|---|---|---|---|---|
Unequivocal | Histopathologic diagnosis | Sensitivity | 72% | 83% |
Specificity | 89% | 89% | ||
Ambiguous | Histopathologic diagnosis | Sensitivity | 50% | 67% |
Specificity | 96% | 96% |
